The acquisition saw the merger of two compatible businesses models, uniting the dynamic management teams and giving HBI a marketing and distribution hub for current and future Scandinavian operations.
A key product in the portfolio is SB12, with exciting worldwide rollout potential
|
2006 |
Acquisition of Sambucol. |
The Sambucol Brand was already established in the US and some European markets. The acquisition represented an opportunity to consolidate the success in these markets and to begin a pan- European roll out programme |
|
|
Acquisition of European rights for docosanol and creation of a new brand |
Docosanol is the leading cold sore active ingedient in the USA. The rights represent an opportunity to market this new active ingredient across Europe |
|
2007 |
Sambucol new market launches |
Sambucol launch in France and Germany with new distributors |
|
|
Achieved OTC Marketing Authorisation in Europe for Erazaban via MRP process |
The new Marketing Authorisation gives an opportunity to market docosonol directly to European consumers |
|
|
Sambucol Partnership with Emerson in the US |
Aggressive channel strategy resulted in high profile listings for Sambucol in mass market as well as healthfood channel |
|
|
Sambucol Supply Chain Improvements |
Manufacturing of Sambucol liquids transferred from Israel to new sites in France and UK. New sites have capability to meet the increasing scale of the business and flexibility of supply to meet the needs of the different markets. |
|
|
Sambucol Product improvements |
Continuous development and improvement program has enhanced the quality of the products and addresses the increasing expectations of the customers. |
|
|
Acquisition of Antula – the fastest growing OTC company in the Nordic region |
The acquisition saw the merger of two compatible businesses models, uniting the dynamic management teams and giving HBI a marketing and distribution hub for current and future Scandinavian operations. |
|
2008 |
Erazaban new market launches |
Erazaban launch in Poland, Czech Republic, Germany and Netherlands |
| 2009 | Sambucol and Erazaban disposals |